Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Conditions:   Pneumococcal Immunisation;   Diphtheria Immunisation;   Tetanus Immunisation;   Pertussis Immunisation;   Hepatitis B Immunisation;   Haemophilus Influenzae Type b Immunisation;   Polio Immunisation;   Measles Immunisation;   Rubella Immunisation;   Varicella Immunisation;   Mumps Immunisation Interventions:   Biological: SP0202-IIb Pneumococcal Conjugate Vaccine formulation 1;   Biological: SP0202-VI Pneumococcal Conjugate Vaccine formulation 2;   Biological: SP0202-VII Pneumococcal Conjugate Vaccine formulation 3;   Biological: Varicella Virus Vaccine Live;   Biological: Measles, Mumps, and Rubella Virus Vaccine Live;   Biological: Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein];   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate);   Biological: Rotavirus Vac cine, Live, Oral, Pentavalent;   Biological: Hepatitis B Vaccine [Recombinant] Sponsor:   Sanofi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials